CI	Confidence interval
CNS	Central nervous system
CTC	Circulating tumor cells
CTCAE	Common Terminology Criteria for Adverse Events
CTLA-4	Anti-cytotoxic lymphocyte antigen-4
DC	Dendritic cell
ECOG	Estearn Cooperative Oncology Group
HR	Hazard ratio
ICI	Immune checkpoint inhibitor
Ig	Immunoglobulin
irAE(s)	Immune-related adverse effect(s)
LDH	Lactate dehydrogenase
MHC	major histocompatibility complex
NK	Natural killer
NSCLC	Non-small cell lung cancer
OS	Overall survival
PD-1	Programmed death protein-1
PD-L1	Programmed death ligand-1
PFS	Progression-free survival
PS	Performance status
RECIST	Response Evaluation Criteria in Solid tumors
TAM	tumor associated macrophage
TCR	T cell receptor
ULN	Upper limit of normal